Vibha Jawa

Chief Scientific Officer at EpiVax, Inc

Speaker

Dr. Vibha Jawa is Chief Scientific Officer of EpiVax, where she leads scientific strategy, guiding research efforts and shaping the company’s approach to new therapies and technologies. Previously, she was Executive Director in the Translational Medicine organization at Bristol Myers Squibb, where she led the biotherapeutic and cell/gene therapy bioanalytical function, supporting PK and immunogenicity in preclinical and clinical development. Vibha also led the Predictive and Clinical Immunogenicity group at Merck and spent 14 years at Amgen supporting Discovery to Development for biotherapeutics. With over 20 years of experience in biologics, vaccines, and gene therapy, she has contributed to 20+ IND, BLA, and MAA filings. A recognized leader in Bioanalysis and Immunogenicity, Vibha has 100+ peer-reviewed publications and serves as a Reviewer and Editor for The AAPS Journal and J. Pharm Sci. She was named an AAPS Fellow in 2022 and received the Bioanalysis Industry Award in 2024.